Inventor
GEFTER MALCOLM L
US41 patents
⚠️ This page may combine multiple inventors who share the name “GEFTER MALCOLM L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PRAECIS PHARM INC
23 patentsUS6180608B1Jan 30, 2001
Pharmaceutical formulations for sustained drug delivery
PRAECIS PHARM INC119 citations99
US5968895AOct 19, 1999
Pharmaceutical formulations for sustained drug delivery
PRAECIS PHARM INC109 citations99
US6303567B1Oct 16, 2001
Modulators of β-amyloid peptide aggregation comprising D-amino acids
PRAECIS PHARM INC142 citations98
US5854204ADec 29, 1998
Aβ peptides that modulate β-amyloid aggregation
PRAECIS PHARM INC230 citations98
US5817626AOct 6, 1998
Modulators of beta-amyloid peptide aggregation
PRAECIS PHARM INC156 citations98
US5985242ANov 16, 1999
Modulators of β-amyloid peptide aggregation comprising D-amino acids
PRAECIS PHARM INC120 citations97
US5854215ADec 29, 1998
Modulators of β-amyloid peptide aggregation
PRAECIS PHARM INC126 citations97
US6211153B1Apr 3, 2001
Methods for treating LHRH associated disorders with LHRH antagonists
PRAECIS PHARM INC51 citations96
US5780435AJul 14, 1998
Methods for treating prostate cancer with LHRH-R antagonists
PRAECIS PHARM INC27 citations96
US6319498B1Nov 20, 2001
Modulators of amyloid aggregation
PRAECIS PHARM INC71 citations95
US6214795B1Apr 10, 2001
Peptide compounds useful for modulating FGF receptor activity
PRAECIS PHARM INC68 citations93
US6699833B1Mar 2, 2004
Pharmaceutical formulations for sustained drug delivery
PRAECIS PHARM INC17 citations92
US6689752B2Feb 10, 2004
Modulators of β-amyloid peptide aggregation comprising D-amino acids
PRAECIS PHARM INC17 citations92
US6277826B1Aug 21, 2001
Modulators of β-amyloid peptide aggregation comprising D-amino acids
PRAECIS PHARM INC36 citations92
US6180609B1Jan 30, 2001
Methods for treating LHRH associated disorders with LHRH antagonists
PRAECIS PHARM INC20 citations92
US5843902ADec 1, 1998
Methods for treating prostate cancer with LHRH antagonists
PRAECIS PHARM INC25 citations92
US7972992B2Jul 5, 2011
Methods for synthesis of encoded libraries
PRAECIS PHARM INC10 citations82
US7935658B2May 3, 2011
Methods for synthesis of encoded libraries
PRAECIS PHARM INC9 citations82
US6384017B1May 7, 2002
Methods for treating sex hormone-dependent conditions with Lhrh antagonists
PRAECIS PHARM INC10 citations82
US7037889B2May 2, 2006
Pharmaceutical compositions for sustained drug delivery
PRAECIS PHARM INC8 citations74
US6153586ANov 28, 2000
Methods for treating prostate cancer with LHRH-R antagonists
PRAECIS PHARM INC5 citations74
US7658917B2Feb 9, 2010
Modulators of amyloid aggregation
PRAECIS PHARM INC5 citations73
US7175828B2Feb 13, 2007
Modulators of β-amyloid peptide aggregation comprising D-amino acids
PRAECIS PHARM INC4 citations61
IMMULOGIC PHARMA CORP
8 patentsUS5876727AMar 2, 1999
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
IMMULOGIC PHARMA CORP115 citations96
US6759234B1Jul 6, 2004
Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
IMMULOGIC PHARMA CORP43 citations92
US6120769ASep 19, 2000
Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
IMMULOGIC PHARMA CORP49 citations92
US6054127AApr 25, 2000
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
IMMULOGIC PHARMA CORP27 citations90
US5760184AJun 2, 1998
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
IMMULOGIC PHARMA CORP36 citations90
US5840307ANov 24, 1998
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
IMMULOGIC PHARMA CORP21 citations89
US6019972AFeb 1, 2000
Peptides of human T cell reactive feline protein (TRFP)
IMMULOGIC PHARMA CORP14 citations81
US6048962AApr 11, 2000
Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
IMMULOGIC PHARMA CORP8 citations73